Current Issue

View Larger Image

Past Issues Free Subscriptions
Sponsored
Keywords



Search Results - Colorectal Cancer
 More »

  • GEN's List of Molecular Millionaires
    FDA approval for a new macular edema indication) and FDA approval of Zaltrap (ziv-aflibercept) injection for IV infusion for use with Folfiri for metastatic colorectal cancer. ...
    10-15-2013
  • Clinical Genomics Nabs Enterix, Aims to Launch New Bowel Cancer...
    Clinical Genomics hopes that the deal will make them a major player in colorectal cancer screening in Australia as it gears up to launch what it says will be the first commercially ...
    10-8-2013
  • Ovarian Cancer Treatment Options Multiply
    ... CGEN-15049 is expressed in ovarian, lung, breast, colorectal, gastric, prostate, and liver ... with standard-of-care therapies for patients with p53-deficiant ovarian cancer. ...
    10-8-2013
  • Designer Baby Patent Awarded to 23andMe
    In the example furnished, a donor specified a preference for a low risk of colorectal cancer and congenital heart defects equally, and to a lesser degree a preference for green ...
    10-4-2013
  • Amgen Plans R&D Center in China
    In May, Amgen and Zhejiang Beta Pharma said they would commercialize Amgen's metastatic colorectal cancer drug (mCRC) Vectibix® (panitumumab) in China through a joint venture. ...
    9-25-2013
  • Takeover Targets: Who Is First on the List?
    ... Regeneron Pharmaceuticals Focus: Discovering, developing, manufacturing, and commercializing medicines for serious medical conditions that include eye diseases, colorectal cancer, ...
    9-24-2013
  • Top 40 Molecular Millionaires
    FDA approval for a new macular edema indication; and FDA approval of Zaltrap (ziv-aflibercept) injection for IV infusion for use with Folfiri for metastatic colorectal cancer. ...
    9-19-2013
  • 3D High-Content Analysis of Spheroids
    cultures generated in the Perfecta3D® Hanging Drop Plates (HDPs) from 3D Biomatrix were used to create a colorectal cancer model for a proof-of-concept drug-validation experiment. ...
    9-15-2013
  • Gene Test Boom Faces Lawsuits
    On Sept. 5, Myriad announced the launch of myRisk Hereditary Cancer(tm), a 25-gene panel covering eight major cancers (breast, colorectal, endometrial, gastric, ovarian, ...
    9-15-2013
  • Manipulating Methodologies for Reprogramming Cells
    ... An additional stride toward understanding genome-wide DNA methylation in disease came about when, in a comparison between colorectal cancer and normal colorectal mucosa from the ...
    9-1-2013
  • Amgen Grows Cancer Holdings with $10.4B Onyx Acquisition
    Stivarga ® (regorafenib) tablets, indicated for metastatic colorectal cancer (CRC) patients previously treated with fluoropyrimidine-, oxaliplatin- and irinotecan-based ...
    8-26-2013
  • GeneNews Axes 60% of Staff to Boost New JV
    on the development and broader U.S. commercialization of ColonSentry®, which the firm says is the first blood test to assess an individual's current risk for colorectal cancer. ...
    8-20-2013
  • NIH Grants $5.2M to Vanderbilt Colon Cancer Investigator
    Jr., M.D., Ingram Professor of Cancer Research at Vanderbilt University, a five-year, $5.2 million grant to study the role of extracellular RNA (ex-RNA) in colorectal cancer. Dr. ...
    8-19-2013
  • Gene Test Boom Faces Lawsuits
    ... Starting in September, Myriad will launch myRisk Hereditary Cancer(tm), a 25-gene panel covering six major cancers (breast, colorectal, endometrial, gastric, ovarian, pancreatic, ...
    8-16-2013
  • Mouth Bacteria Linked to Colorectal Cancer
    The findings could lead to more effective strategies for the early diagnosis, prevention, and treatment of colorectal cancer, say the scientists. "Fusobacteria may provide not only ...
    8-15-2013
  • More »

    Journal Articles

  • Colorectal Cancer Survivors' Interest in Genetic Testing for...
    Deborah Cragun, Teri L. Malo, Tuya Pal, David Shibata, Susan T. Vadaparampil
    Genetic Testing and Molecular Biomarkers
    Colorectal Cancer Survivors' Interest in Genetic Testing for Hereditary Cancer: Implications for Universal Tumor Screening Genetic Testing and Molecular Biomarkers Aims: Benefits ...
  • Colorectal Cancer Screening Practices among Obstetrician/Gynecologists...
    Stacy B. Menees, Divya A. Patel, Vanessa Dalton
    Journal of Women's Health
    Colorectal Cancer Screening Practices among Obstetrician/Gynecologists and Nurse Practitioners Journal of Women's Health Abstract Objective: Obstetrician/gynecologists (Ob/Gyn) and ...
  • Colorectal Cancer Screening Compliance and Contemplation in Gynecology...
    Stacy B. Menees, John Inadomi, Grace Elta, Sheryl Korsnes, Margaret Punch, Leslie Aldrich
    Journal of Women's Health
    Colorectal Cancer Screening Compliance and Contemplation in Gynecology Patients Journal of Women's Health Abstract Objective: Colorectal cancer screening (CRCS) should be a ...
  • Knowledge About Hereditary Colorectal Cancer Among Colorectal...
    Susan T. Vadaparampil, Gwendolyn Quinn, Teri L. Malo, Angelic Alvarez, Cheryl A. Miree, David Shibata
    Genetic Testing and Molecular Biomarkers
    Knowledge About Hereditary Colorectal Cancer Among Colorectal Cancer Survivors Genetic Testing and Molecular Biomarkers Aim: Little is known about colorectal cancer (CRC) patients' ...

GEN Webinars

View »

GEN Web Briefs

View »

GEN Poll

More » Poll Results » Archive »

Balancing Family and Career for Women Ph.D.s

Which changes made to academic culture are most likely to encourage women researchers to stay?

Suggest a Poll